PATENT CLAIM ANALYSIS

Application Number: 16202487
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "759000"]

Abstract:
The present invention relates to a polymorph of a compound of formula (I) This polymorph is particularly suitable in treating IPF by pulmonary administration.

Claim (Index 1):
A polymorph of a compound of formula (I) wherein the polymorph is 3,3\u2032-Dideoxy-3,3\u2032-bis-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1\u2032-sulfanediyl-di-\u03b2-D-galactopyranoside and wherein:\n the polymorph has a polymorphic form 1 as identified in the following XRPD diffractogram peak list: \n No. Pos. [\u00b02Th.] Rel. Int. [%] 1 7.1269 77.72 2 7.5067 56 3 10.125 36.86 4 14.3791 32.28 5 15.0846 18.59 6 15.8201 35.78 7 16.7088 78.1 8 18.6001 21.29 9 19.7777 100 10 20.3353 57.04 11 21.7744 79.92 12 22.6053 35.8 13 23.4305 45.78 14 24.3658 51.03 15 25.8091 54.36 16 26.7046 25.38 17 29.028 16.19 18 30.2989 28.02 19 32.2693 14.86 20 33.5132 11.55 21 34.6078 11.54 22 35.8435 9.6 23 44.6257 22.73; \u2003or the polymorph has a polymorphic form 1 as identified in the XRPD diffractogram in  FIG. 1 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16062206', '15323967', '14438977', '14966427', '13832672']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7637883535046405
- 35 USC 102 Novelty (BERT): 0.5876899816460507
- Combined Prediction Score: 0.7461785163187815
- Mean Citation Score: 303.12529
- Max Citation Score: 551.9757
- Similarity Product: 396.0472866032839

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test